Last updated on October 2012

Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Hepatocellular | Carcinoma
  • Age: Between 20 - 79 Years
  • Gender: Male or Female
  • Other:
    Subject must be histologically or clinically proven HCC, inoperable, no indication of
    local treatment and has measurable lesions.
    Subject must to be the first experience of TACE.
    Subject has no extra-hepatic tumor and no obstruction of main portal vein.
    Subjects must have fully recovered from previous treatment (at least 4 weeks interval
    is needed from prior chmotherapy or radiation therapy).
    ECOG performance status 0-2
    Child-pugh Class A or B
    Subject must have adequate functions of bonemarrow, renal, circulatory organs and
    appropriate examination results as below:
    Serum Total Bilirubin 2.0mg/mL
    WBC 3000/mm3
    PLT 50000/mm3
    Hb 9.0g/dL
    Creatinine ; upper normal limit (UNL)
    BUN 25mg/dL
    Written informed consent

You may not be eligible for this study if the following are true:

  • Subject has extra hepatic metastasis.
    Tumor thrombosis exists at main portal vein.
    Remarkable artery-portal vein shunt or veno-arterial shunt.
    Uncontrollable ascites or pleural effusion.
    History of severe hypersensitivity.
    Any previous TACE or TAE for HCC.
    Any previous chemotherapy using epirubicin or CDDP.
    Complications as below (except chronic hepatitis or liver cirrhosis)
    Severe heart disease
    Myocardial infarction within 6 months
    Renal insufficiency
    Active infections (except virous hepatitis)
    Gastrointestinal bleeding
    Active double cancer
    Hepatic encephalopathy or heavy mental disorder.
    Pregnancy or lactation women, or women with suspected pregnancy or men with willing
    to get pregnant.
    Any subject judged by the investigator to be unfit for any reason to participate in
    the study.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.